In the assessment of 12-month price targets, analysts unveil insights for Lexicon Pharmaceuticals, presenting an average ...
6h
Zacks Investment Research on MSNWhy the Market Dipped But Merck (MRK) Gained TodayIn the latest trading session, Merck (MRK) closed at $89.23, marking a +1.86% move from the previous day. This move outpaced the S&P 500's daily loss of 1.97%. Meanwhile, the Dow experienced a drop of ...
6h
Zacks Investment Research on MSNVertex Pharmaceuticals (VRTX) Stock Moves -1.96%: What You Should KnowVertex Pharmaceuticals (VRTX) closed the latest trading day at $492.69, indicating a -1.96% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of ...
The global Analytical Standards Market, valued at US$1.44 billion in 2022, is forecasted to grow at a robust CAGR of 5.9%, reaching US$1.53 ...
The high-stakes nature of cancer care, coupled with rapid scientific advancements, increasing payer and regulatory pressures, ...
Acadia (ACAD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Trump tariffs — aimed at boosting U.S. jobs and tax revenues — will also affect imported auto parts, which were valued ...
The program for Purdue-connected companies offers the university a way to rekindle or establish the startup founders' Indiana ...
Value stocks aren't typically the most exciting investments, but they can often provide steady capital gains without causing investors to lose any sleep during periods of market volatility.
FY 2024 net product revenues increased 140% to $607.6 thousand.FY 2024 gross profit increased $443.8 thousand from ($221 thousand) to $222.8 ...
Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends in the pharmaceutical sector.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results